Gene synthesis for swine flu vaccine supported by ISO 9001 processes
In April 2009, ISO 9001:2000-certified Geneart AG, the world-wide leading supplier for synthetic genes, produced genes for the development of a vaccine against swine flu in just 3 to 5 days, a remarkable achievement considering the first cases had been reported only 2 weeks prior.
Since 2005 all of Geneart's processes have conformed with ISO 9001:2000 Quality management systems – Requirements. The German-based company is reportedly the first gene synthesis provider to have achieved this distinction.
...
[more]STANDARD IN DEVELOPMENT
Pharmacy services Standard
Committee: P8120
Project Manager: Carolyn Gay
Estimated Publication Date: March 2010
Comments: The Pharmacy services Standard is progressing well. A balanced expert committee from across the sector is working to ensure the Standard demonstrates that consumers are clear about their rights, and providers are clear about their responsibilities for good and safe outcomes. The committee met at the end of October to review the comments received from the public comment phase of the project. The draft is being updated to reflect the committee's decisions and will be ready for postal ballot in February.